Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
BENEVOLENTAI
BenevolentAI
Biotechnology/AI · United Kingdom · Founded · 2014

BenevolentAI Stock: No Ticker, Three Exposure Routes

Company

BenevolentAI is a private company, so there is no BenevolentAI ticker and no quoted share price. Three exposure routes exist in the private market; one needs no accreditation.

ProfileValuationFundingCompetitorsStock & IPOHow to invest
BenevolentAI exposure · at a glance
Company status
· no ticker
founded 2014
Exposure routes that exist
3routes
ranked below
Last disclosed valuation
$2B
PRE-MONEY · APR 2018
Nearest Canborsa market
NVDA—
NVDA-PERP · live
Three routes · ranked by accessibility

The routes that exist, and what each one really gives you

If you came here to buy BenevolentAI stock, there is nothing to buy on an exchange: no public ticker exists. What follows is ranked by how easily an ordinary investor can start. Whether BenevolentAI shares are on offer through a private route at a given moment is up to the holders.

ROUTE Aany investor

Listed funds that hold private companies

A handful of listed closed-end and venture funds carry late-stage private names in their portfolios. You buy the fund in any brokerage account; the private company is one position inside it. A fund's latest schedule of investments shows whether it holds BenevolentAI.

BenevolentAI holding · fund-specific
Pros
✓Works in an ordinary brokerage account
✓No accreditation, no company approval
✓Sellable on any trading day
Cons
—You own fund shares, and BenevolentAI may not be in the portfolio at all
—Closed-end funds have traded at large premiums to NAV
—Any single position is a slice — the rest of the book moves your return too
ACCESSAny brokerage that lists the fund · no minimum beyond one share · read the latest holdings report and the premium to NAV before you assume BenevolentAI is in there
ROUTE Baccredited only

Secondary marketplaces

Platforms that match existing shareholders with buyers. This is the route that can end with private shares, or an interest in a vehicle holding them, in your account. Supply comes from employees and early investors choosing to sell, so a name can be quoted one month and absent the next.

BenevolentAI availability · set by holders
Pros
✓Direct exposure to the equity itself
✓Pricing follows recent private-market sales
✓A position taken now survives into an eventual listing
Cons
—Accredited-investor status is verified before you can bid
—The company must approve the transfer and usually holds a right of first refusal
—Five-figure minimums and weeks of settlement; no exit until a liquidity event
ACCESSAccredited investor · platform onboarding and KYC · company transfer approval plus the refusal window before settlement
ROUTE Cinvitation only

Employee-share vehicles

Single-purpose vehicles and forward contracts written against shares held by employees and early investors. The sponsor holds the position; you hold an interest in the sponsor's vehicle. Deals circulate through fund networks; there is no public order book for them.

BenevolentAI vehicles · by invitation
Pros
✓Reaches allocations that never appear on a marketplace
✓The vehicle can participate in a future tender
✓Sponsors handle the paperwork and the cap-table mechanics
Cons
—You are one layer removed from the cap table
—Management and carry fees stack on top of the share price
—Transfer restrictions can invalidate a structure the company never approved
ACCESSInvitation or qualified-purchaser status · counsel should read the vehicle documents before you subscribe · minimums are set by the sponsor
FINAL STEPnot a route today

Track the IPO

BenevolentAI has not announced an IPO. Until a public filing exists there is nothing to allocate, nothing to price and nothing to trade.

WATCHA public IPO filing opens the listed route
A filing is not a commitment to list. Companies withdraw drafts, and no date exists until the company sets one.
Comparison · every route in one table

The routes side by side

The first row is the Canborsa market closest to BenevolentAI: a perpetual on NVDA, open in minutes with an email and USDC. The three routes below it are the ways to hold BenevolentAI shares, ranked by how easily an ordinary investor can start.

Route
Access requirement
Typical minimum
Liquidity
Ends with shares?
Canborsa· NVDA-PERP—Sign upnearest market to BenevolentAI · live
Email, X or a wallet + USDC
from $1
24/7 · perpetual market
No — perp exposure on NVDA
A · Listed fundsindirect · via a fund
A brokerage account that lists the fund — no accreditation
one fund share
Daily, on-exchange
No — fund shares
B · Secondary marketplacesshare ownership
Accredited investor, company transfer approval, refusal window
five figures, platform-set
Weeks — approval-gated
Yes — with restrictions
C · Employee-share vehiclesshare ownership · indirect
An invitation from the sponsor, plus qualified-purchaser status in most structures
set by the sponsor
At a future tender or exit
Indirect — via the vehicle
Canborsa — a perpetual on NVDA, price exposure without sharesshare ownership — you sit on or behind the cap tablefund exposure
Keep exploring
More in Biotechnology
Retro Biosciences competitorscompetitors›Insitro valuationvaluation›Formation Bio funding historyfunding›Lila Sciences profilecompany · profile›All companiesdirectory›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
Cerebras Systems (CBRS)US equity · perp›ChangXin Memory Technologies (CXMT)Asian equity · perp›SpaceX (SPCX)US equity · perp›Palantir (PLTR)US equity · perp›All 86 marketsindex›

Frequently asked questions

Is BenevolentAI publicly traded?›

No. BenevolentAI is a private company; its shares do not trade on a public exchange.

What is BenevolentAI's valuation?›

The last valuation is $2B.

Who has invested in BenevolentAI?›

Lead investors for each round are in the funding timeline.

Who are BenevolentAI's competitors?›

The closest biotechnology/ai peers are on the competitors page.

US equity · Perpetual · 20x

Trade NVDA-PERP on Canborsa

NVIDIA · the Canborsa market closest to BenevolentAI
0.07% per side—Launch App ›NVDA market
SpaceXAnthropicbKashAkulakuBlaBlaCarAll companies ›
© Canborsa 2026TermsPrivacy